Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laboratorios Garden House Farmacéutica is a prominent Latin American company focused on the development and commercialization of natural-origin pharmaceutical products and dietary supplements. Established in Chile in 1984, the company has expanded its footprint to include significant operations in Argentina, Mexico, and Peru, becoming a leader in the regional phytotherapy market. Its extensive portfolio includes well-recognized brands targeting weight loss, digestive health, and general wellness, such as the Redugras line. In 2014, Garden House was acquired by Grupo Biotoscana (GBT), which was later integrated into Knight Therapeutics in 2019. The company maintains a strong focus on high-quality manufacturing and natural health solutions, leveraging its established brand equity across South and Central America.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laboratorios Garden House Farmacéutica.